| |
|
|
Bukwang Pharmaceutical Co.,Ltd (003000) |
|
|
STOCK |
|
|
|
  |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2007. 3.31 | 2008. 3.31 | 2009. 3.31 | 2010. 3.31 | 2010. 9.30 |
| Cash & Cash Equivalents | 373.1 | 291.5 | 191.1 | 253.6 | 228.1 |
| Short-term Financial Instruments | 0.8 | 280.0 | 100.0 | 50.0 | 0.0 |
| Marketable securities | 1.7 | 2.3 | 2.5 | 2.9 | 3.7 |
| Account receivables | 459.8 | 552.6 | 709.6 | 890.7 | 925.4 |
| TOTAL QUICK ASSETS | 842.8 | 1,140.0 | 1,025.2 | 1,223.7 | 1,174.0 |
| TOTAL INVENTORY | 190.9 | 333.7 | 367.1 | 373.1 | 378.8 |
| TOTAL CURRENT ASSETS | 1,033.8 | 1,473.8 | 1,392.3 | 1,596.8 | 1,552.9 |
| TOTAL INVESTMENTS ASSETS | 66.6 | 68.6 | 64.8 | 61.4 | 60.5 |
| TOTAL TANGIBLE ASSETS | 337.8 | 500.7 | 713.2 | 742.6 | 777.4 |
| TOTAL INTANGIBLE ASSETS | 33.5 | 29.0 | 62.5 | 85.3 | 96.7 |
| TOTAL OTHER NON-CURRENT ASSETS | 22.8 | 31.4 | 29.3 | 19.1 | 19.1 |
| TOTAL NON-CURRENT ASSETS | 460.9 | 629.8 | 869.9 | 908.5 | 953.9 |
| TOTAL ASSETS | 1,494.7 | 2,103.6 | 2,262.3 | 2,505.4 | 2,506.9 |
| Trade account payable | 50.1 | 71.3 | 50.7 | 74.2 | 71.8 |
| Short-term borrowings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Current portion of long-term liabilities | 0.0 | 0.0 | 0.0 | 0.0 | 300.0 |
| TOTAL CURRENT LIABILITIES | 217.8 | 409.5 | 226.1 | 234.2 | 545.5 |
| Total bonds | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term borrowings | 0.0 | 0.0 | 300.0 | 300.0 | 0.0 |
| TOTAL NON-CURRENT LIABILITIES | 35.1 | 31.6 | 337.6 | 353.1 | 66.4 |
| TOTAL LIABILITIES | 252.9 | 441.2 | 563.7 | 587.3 | 611.9 |
| Capital stocks | 122.8 | 128.8 | 135.2 | 135.2 | 135.2 |
| Capital surplus | 133.2 | 257.1 | 257.1 | 257.1 | 257.1 |
| Retained Earnings(Deficit) | 1,047.9 | 1,299.4 | 1,498.5 | 1,711.8 | 1,684.9 |
| TOTAL STOCKHOLDERS EQUITY | 1,241.8 | 1,662.4 | 1,698.5 | 1,918.0 | 1,894.9 |
|
 |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2007. 3.31 | 2008. 3.31 | 2009. 3.31 | 2010. 3.31 | 2010. 9.30 |
| SALES(NET) | 1,375.2 | 1,556.0 | 1,614.4 | 1,708.1 | 848.8 |
| Cost of Sales | 602.2 | 583.2 | 650.7 | 726.5 | 367.0 |
| GROSS PROFIT | 773.0 | 972.8 | 963.7 | 981.5 | 481.7 |
| Seling & General Admin. Expenses | 508.0 | 551.2 | 562.7 | 590.8 | 316.0 |
| OPERATING INCOME | 264.9 | 421.6 | 400.9 | 390.7 | 165.7 |
| NON-OPERATING INCOME | 24.0 | 51.7 | 34.1 | 21.4 | 8.8 |
| Gain on valuation using equity method of accounting | - | - | - | - | - |
| NON-OPERATING EXPENSES | 12.6 | 18.0 | 35.8 | 43.6 | 15.7 |
| Loss on valuation using equity method of accounting | 1.3 | 0.3 | 3.8 | 2.8 | 0.9 |
| Ongoing Business Income(Loss) Before Income Taxes Expenses | 276.3 | 455.2 | 399.3 | 368.6 | 158.8 |
| Income Taxes Expenses for Ongoing Business Income or Loss | 80.9 | 126.6 | 90.8 | 89.8 | 53.7 |
| ONGOING BUSINESS INCOME(LOSS) | 195.4 | 328.5 | 308.4 | 278.7 | 105.1 |
| DISCONTINUED OPERATION INCOME(LOSS) | - | - | - | - | - |
| NET INCOME | 195.4 | 328.5 | 308.4 | 278.7 | 105.1 |
|
 |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2007. 3.31 | 2008. 3.31 | 2009. 3.31 | 2010. 3.31 | 2010. 9.30 |
| Cash flows from operating activities |
232.6 | 264.3 | - 24.7 | 154.1 | 136.3 |
| Add.of Cost without outflow of Cash |
67.2 | 61.8 | 87.5 | 104.1 | 55.2 |
| Depreciation |
32.7 | 35.0 | 34.5 | 26.7 | 26.7 |
| Deduc.of Rev.without inflow of Cash |
2.1 | 3.9 | 3.8 | 3.8 | 1.9 |
| Loss on Disposition of Invest.Assets |
3.6 | 4.5 | 0.1 | 0.8 | 0.0 |
| Changes in Ass. & Liab. resulting from operating Activities |
- 26.3 | - 121.4 | - 420.5 | - 227.8 | - 23.9 |
| Cash flows from investing activities |
- 62.8 | - 485.1 | - 103.3 | - 12.4 | - 30.0 |
| Inflow of cash |
991.5 | 569.1 | 385.0 | 104.6 | 920.4 |
| Outflow of cash |
1,054.3 | 1,054.2 | 488.3 | 117.1 | 950.5 |
| Cash flows from financing activities |
- 47.4 | 139.2 | 27.6 | - 79.1 | - 131.9 |
| Inflow of cash |
- | 233.5 | 350.0 | - | - |
| Outflow of cash |
47.4 | 94.3 | 322.4 | 79.1 | 131.9 |
| Increase in Cash |
122.4 | - 81.5 | - 100.4 | 62.5 | - 25.5 |
|
|
|
|
